Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1962 2
1965 3
1966 1
1967 1
1972 1
1977 1
1979 1
1983 1
1985 1
1987 3
1989 2
1990 2
1991 2
1993 3
1994 2
1995 2
1996 3
1997 2
1998 2
1999 3
2000 4
2001 10
2002 5
2003 11
2004 3
2005 8
2006 10
2007 16
2008 17
2009 19
2010 25
2011 37
2012 33
2013 41
2014 43
2015 58
2016 44
2017 43
2018 59
2019 45
2020 59
2021 63
2022 78
2023 90
2024 80
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

821 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial.
Chan ATC, Lee VHF, Hong RL, Ahn MJ, Chong WQ, Kim SB, Ho GF, Caguioa PB, Ngamphaiboon N, Ho C, Aziz MASA, Ng QS, Yen CJ, Soparattanapaisarn N, Ngan RK, Kho SK, Tiambeng MLA, Yun T, Sriuranpong V, Algazi AP, Cheng A, Massarelli E, Swaby RF, Saraf S, Yuan J, Siu LL. Chan ATC, et al. Among authors: yun t. Ann Oncol. 2023 Mar;34(3):251-261. doi: 10.1016/j.annonc.2022.12.007. Epub 2022 Dec 16. Ann Oncol. 2023. PMID: 36535566 Free article. Clinical Trial.
Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses.
Sulczewski FB, Maqueda-Alfaro RA, Alcántara-Hernández M, Perez OA, Saravanan S, Yun TJ, Seong D, Arroyo Hornero R, Raquer-McKay HM, Esteva E, Lanzar ZR, Leylek RA, Adams NM, Das A, Rahman AH, Gottfried-Blackmore A, Reizis B, Idoyaga J. Sulczewski FB, et al. Among authors: yun tj. Nat Immunol. 2023 Aug;24(8):1265-1280. doi: 10.1038/s41590-023-01545-7. Epub 2023 Jul 6. Nat Immunol. 2023. PMID: 37414907 Free PMC article.
Ontogeny and Function of Plasmacytoid Dendritic Cells.
Adams NM, Das A, Yun TJ, Reizis B. Adams NM, et al. Among authors: yun tj. Annu Rev Immunol. 2024 Jun;42(1):347-373. doi: 10.1146/annurev-immunol-090122-041105. Annu Rev Immunol. 2024. PMID: 38941603 Free article. Review.
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial.
Keam B, Hong MH, Shin SH, Heo SG, Kim JE, Ahn HK, Lee YG, Park KU, Yun T, Lee KW, Kim SB, Lee SC, Kim MK, Cho SH, Oh SY, Park SG, Hwang S, Nam BH, Kim S, Kim HR, Yun HJ; KCSG TRIUMPH Investigators. Keam B, et al. Among authors: yun t. J Clin Oncol. 2024 Feb 10;42(5):507-517. doi: 10.1200/JCO.22.02786. Epub 2023 Sep 12. J Clin Oncol. 2024. PMID: 37699162 Clinical Trial.
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance.
Çoku J, Booth DM, Skoda J, Pedrotty MC, Vogel J, Liu K, Vu A, Carpenter EL, Ye JC, Chen MA, Dunbar P, Scadden E, Yun TD, Nakamaru-Ogiso E, Area-Gomez E, Li Y, Goldsmith KC, Reynolds CP, Hajnoczky G, Hogarty MD. Çoku J, et al. Among authors: yun td. EMBO J. 2022 Apr 19;41(8):e108272. doi: 10.15252/embj.2021108272. Epub 2022 Feb 25. EMBO J. 2022. PMID: 35211994 Free PMC article.
821 results